**US Fears Rising Over Dependence on Chinese Ingredients in Drugs** In a recent development that has sent shockwaves across the globe, the United States is growing increasingly concerned about its reliance on China for essential ingredients in its pharmaceutical industry. This worry stems from China's aggressive push to dominate the world's pharmaceutical market, much like it has done in other sectors such as rare earth minerals, semiconductors, and electric vehicles. According to US lawmakers, China is strategically positioning itself to control not just the generic drugs that Americans rely on daily, but also the cutting-edge biotech innovations that will shape the future of medicine. This concern was highlighted at a recent hearing of the House Select Committee on China, where lawmakers expressed fears that China's growing influence in the pharmaceutical sector could compromise the safety and security of US medicine. One of the concerns is that China is executing a long-term strategy to move up the pharmaceutical value chain, which could ultimately give it control over the entire supply chain. As the US relies heavily on China for its pharmaceutical ingredients, any disruption or manipulation of this supply chain could have severe consequences for American healthcare. The Chinese pharmaceutical market is expected to experience significant growth, driven by the country's ageing population and its expanding global presence. By 2030, the industry is projected to generate over $2.1 trillion in revenue, according to UBS estimates. This growth has raised concerns among US lawmakers, who fear that China's dominance in the sector could compromise the US's ability to respond to public health crises and ensure the safety and efficacy of its medicines. As the US continues to grapple with the implications of its dependence on Chinese pharmaceutical ingredients, it remains to be seen how this situation will unfold. One thing is clear, however: the stakes are high, and the US must carefully navigate this complex issue to ensure the continued safety and security of its medicine.